- Home
- Products
Mitotane (Lysodren)
Mitotane (Lysodren)
- Medicine Name: Lysodren
- Generic Name: Mitotane
- Dosage Form & Strength: Tablets – 500 mg
- Manufactured By:Bristol-Myers Squibb
Lysodren (Mitotane) is an adrenal cytotoxic agent prescribed for the treatment of inoperable adrenocortical carcinoma (ACC), including both functional and nonfunctional tumors. It works by selectively targeting and destroying adrenal cortex cells to manage the symptoms and slow the progression of this rare cancer. Lysodren is primarily used in cases where surgery is not feasible. Treatment requires close monitoring due to the potential for significant side effects.
Recommended Dosage:
Initial dosing typically starts between 2 g and 6 g per day, divided into 3 or 4 doses. Dosage may be adjusted based on patient tolerance and blood concentration levels. Target mitotane plasma levels are 14–20 mg/L. Therapy continues until disease progression or unacceptable toxicity.
- Central nervous system (CNS) toxicity, including symptoms like lethargy, confusion, dizziness, and unsteadiness, may occur. Monitor and reduce dosage if necessary.
- Ovarian macrocysts have been observed in premenopausal women. Monitor reproductive health.
- Blood disorders including low white blood cells and anemia may develop. Routine blood tests are recommended.
- Lysodren may prolong bleeding time. Use caution with blood thinners.
- May cause harm to a developing fetus. Not recommended during pregnancy. Effective contraception is advised during and after treatment.
- Lysodren may be excreted in breast milk. Breastfeeding should be avoided during treatment and for some time afterward.
Documents required to import Lysodren to India:
- Valid prescription from a licensed oncologist
- Diagnostic reports confirming condition
- Government-issued ID proof of the patient
Order Confirmation:
Orders are confirmed after submission of valid prescription and applicable import permits.
Availability in India:
Lysodren 500 mg is not locally registered but can be imported legally under the Named Patient Program. GlobalRareMeds assists in identifying verified international sources and managing the entire regulatory process.
GlobalRareMeds sources Lysodren (Mitotane) from certified global suppliers across the USA, Canada, and Europe.
We ensure:
- Verified international sourcing
- Prescription validation by registered pharmacists
- Direct delivery from our Fulfillment Center in Ambernath, Thane District
- Reliable and timely delivery across India and globally
For pricing and availability, contact:
📞 +91-99675 15602
📧 info@globalraremeds.com
📱 WhatsApp: +91-99675 15602
What is the generic name of Lysodren?
Mitotane
Who manufactures Lysodren?
Bristol-Myers Squibb
Is Lysodren approved by regulatory authorities?
Yes, Lysodren is FDA-approved. Approval Date: January 18, 2002.
What dosage form is available?
Tablets of 500 mg strength for oral use.
What are the common side effects of Lysodren?
Patients may experience nausea, vomiting, loss of appetite, dizziness, gastrointestinal discomfort, fatigue, mood changes, and cholesterol changes. Regular monitoring is advised.
How can I access Lysodren in India?
GlobalRareMeds helps patients legally import Lysodren through proper regulatory channels based on a valid prescription.
Can Lysodren be supplied outside India?
YesHere is the revised and SEO-optimized product page for NAVELBINE 50mg, tailored for GlobalRareMeds with all references appropriately updated:
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
